Arrowhead Pharmaceuticals, Inc. bonds ARWR
Who owns Arrowhead Pharmaceuticals, Inc.'s debt and what their own filings say it is worth. Bond prices and yields are fund-reported marks (SEC Form N-PORT) as of Jul 2026; they lag the market by about two months. ARWR stock page.
Every bond funds hold
Each bond's latest fund-reported mark. Price per 100 of face value; yield to maturity from price, coupon and maturity; spread over the matched-maturity Treasury for US-dollar bonds.
| Bond | Coupon | Maturity | Ccy | Price | Yield | Spread | Funds | Held | As of |
|---|---|---|---|---|---|---|---|---|---|
| 04280AAC4 convertible | 0% none | 2032-01-15 | USD | 124.12 | — | — | 18 | $79.9M | Jul 2026 |
Spread history
Median spread of the US-dollar bonds over Treasuries, month-ends with complete filings. Fund-reported.
Not enough US-dollar bonds with a yield.
Price history
Median fund-marked price across the bonds, per 100 of face value.
By month
Funds file on staggered quarter-ends, so each month-end is marked by the funds that reported for it; the amount held moves with which funds filed, not only with buying and selling.
| Month-end | Bonds | Held | Median price | USD yield | USD spread | Most funds on one bond |
|---|---|---|---|---|---|---|
| Jul 2026 | 1 | $79.9M | 124.12 | — | — | 18 |
| Jun 2026 | 1 | $27.2M | 119.97 | — | — | 24 |
| May 2026 | 1 | $6.8M | 117.30 | — | — | 5 |
| Apr 2026 | 1 | $59.1M | 113.99 | — | — | 18 |
| Mar 2026 | 1 | $21.7M | 103.63 | — | — | 26 |
| Feb 2026 | 1 | $12.2M | 105.31 | — | — | 8 |
| Jan 2026 | 1 | $55.9M | 112.58 | — | — | 22 |
Who holds the debt
Fund series in their latest quarterly N-PORT report, largest first, with the change in face value against each fund's own previous report. Names as reported in the filings. 7 added, 18 cut, 10 new holders and 16 exits in the latest quarter.
| Fund series | Report | Face value | Value | Change in face value |
|---|---|---|---|---|
| NYLIM MacKay Convertible Fund NYLIM FUNDS | 2026-07-31 | $16.0M | $19.8M | $6.3M |
| iShares Convertible Bond ETF iShares Trust | 2026-07-31 | $14.7M | $18.3M | $2.2M |
| Calamos Market Neutral Income Fund CALAMOS INVESTMENT TRUST/IL | 2026-07-31 | $13.7M | $17.1M | $0 |
| State Street(R) SPDR(R) Bloomberg Convertible Securities ETF SPDR SERIES TRUST | 2026-06-30 | $11.1M | $13.4M | $2.0M |
| NYLIM VP MacKay Convertible Portfolio NYLIM VP FUNDS TRUST | 2026-06-30 | $6.8M | $8.2M | $5.5M |
| Fidelity Convertible Securities Fund Fidelity Financial Trust | 2026-05-31 | $4.1M | $4.9M | $0 |
| CALAMOS CONVERTIBLE & HIGH INCOME FUND | 2026-07-31 | $3.0M | $3.7M | $0 |
| Calamos Convertible Fund CALAMOS INVESTMENT TRUST/IL | 2026-07-31 | $2.8M | $3.4M | $0 |
| CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | 2026-07-31 | $2.8M | $3.4M | $0 |
| Calamos Dynamic Convertible & Income Fund | 2026-07-31 | $2.2M | $2.8M | $0 |
| Invesco Convertible Securities Fund AIM Growth Series (Invesco Growth Series) | 2026-06-30 | $2.0M | $2.4M | -$1.2M |
| Virtus Convertible & Income Fund | 2026-07-31 | $1.7M | $2.1M | new |
| Advent Convertible & Income Fund ADVENT CONVERTIBLE & INCOME FUND | 2026-07-31 | $1.5M | $1.9M | -$593K |
| Fidelity Strategic Dividend and Income Fund Fidelity Salem Street Trust | 2026-05-31 | $1.6M | $1.8M | -$185K |
| Virtus Convertible & Income Fund II | 2026-07-31 | $1.4M | $1.7M | new |
| Virtus Equity & Convertible Income Fund | 2026-07-31 | $1.3M | $1.6M | new |
| Virtus Dividend, Interest & Premium Strategy Fund | 2026-07-31 | $1.3M | $1.6M | new |
| Virtus Diversified Income & Convertible Fund | 2026-07-31 | $1.0M | $1.3M | new |
| Simplify Opportunistic Income ETF Simplify Exchange Traded Funds | 2026-06-30 | $800K | $958K | $0 |
| First Trust SSI Strategic Convertible Securities ETF First Trust Exchange-Traded Fund IV | 2026-07-31 | $461K | $571K | $0 |
| Loomis Sayles Strategic Income Fund LOOMIS SAYLES FUNDS II | 2026-06-30 | $435K | $519K | -$560K |
| Loomis Sayles Investment Grade Bond Fund LOOMIS SAYLES FUNDS II | 2026-06-30 | $314K | $375K | new |
| American Beacon SSI Alternative Income Fund AMERICAN BEACON FUNDS | 2026-06-30 | $231K | $276K | $0 |
| BNY Mellon Core Plus Fund BNY Mellon Absolute Insight Funds, Inc. | 2026-07-31 | $200K | $248K | -$100K |
| Harbor Ares Systematic Convertible Securities Fund HARBOR FUNDS | 2026-07-31 | $200K | $248K | $100K |
Largest exits in the latest quarter (fund held the bonds in its previous report, none now): Columbia Convertible Securities Fund ($5.0M), Putnam Convertible Securities Fund ($924K), Bancroft Fund Ltd ($825K), Ellsworth Growth & Income Fund Ltd ($825K), Defensive Market Strategies Fund ($603K), CALAMOS STRATEGIC TOTAL RETURN FUND ($538K), Gabelli Convertible & Income Securities Fund Inc ($440K), Calamos Growth & Income Fund ($417K), Empower High Yield Bond Fund ($326K), Voya Global Income & Growth Fund ($240K).
ETFs holding these bonds
From each ETF's own latest N-PORT report: the issuer's bonds as a share of the ETF's net assets. A holdings list, not a recommendation.
| ETF | Report | Bonds | Face value | Value | % of net assets |
|---|---|---|---|---|---|
| ICVT iShares Convertible Bond ETF | 2026-07-31 | 1 | $14.7M | $18.3M | 0.25% |
| CWB State Street(R) SPDR(R) Bloomberg Convertible Securities ETF | 2026-06-30 | 1 | $11.1M | $13.4M | 0.22% |
| CRDT Simplify Opportunistic Income ETF | 2026-06-30 | 1 | $800K | $958K | 2.64% |
| FCVT First Trust SSI Strategic Convertible Securities ETF | 2026-07-31 | 1 | $461K | $571K | 0.57% |
Default risk, three ways
Stock market: distance-to-default
Distance-to-default 4.88: safer than 48% of companies (45th percentile in Healthcare). Market-implied, prices to 2026-10-16, balance sheet 2026-06-30.
| Equity value | $8.08B |
| Debt barrier (short-term + ½ long-term debt) | $452.0M |
| Equity volatility (1 year) | 60.7% |
| Asset value / asset volatility (solved) | $8.51B / 57.6% |
| Risk-free rate (1-year Treasury) | 4.28% |
Bond market: priced-in odds
No US-dollar bond with a yield to compute it from.
Accounts: Altman Z
Altman Z'' = 1.13 (latest balance sheet). A fundamentals cross-check; see methods for the variant used.
The stock side: 13F filings
What institutions report holding in ARWR's stock and options. Options are reported at the value of the underlying shares, not the premium paid; 13F lists long positions only, lags 45 days after quarter-end, and does not show whether puts hedge a stock position.
| Quarter-end | Stock holders | Stock value | Put managers | Puts (underlying value) | Call managers | Calls (underlying value) | Convertible holders |
|---|---|---|---|---|---|---|---|
| 2026-09-30 filings still arriving | 40 | $66.1M | 0 | — | 1 | $42K | 3 |
| 2026-06-30 | 490 | $9.63B | 13 | $64.7M | 15 | $157.0M | 44 |
| 2026-03-31 | 420 | $6.39B | 13 | $54.7M | 15 | $105.7M | 42 |
| 2025-12-31 | 387 | $7.56B | 9 | $38.8M | 15 | $145.4M | 0 |
| 2025-09-30 | 293 | $3.81B | 6 | $9.4M | 10 | $34.1M | 0 |
| 2025-06-30 | 269 | $1.65B | 12 | $9.5M | 12 | $7.6M | 0 |
Sources: fund holdings and fund-reported marks from SEC Form N-PORT (published about 60 days after each month-end); 13F filings; House and Senate periodic transaction reports and OGE Form 278-T; Treasury yields from FRED. Findings from filings, not advice. How each number is computed.